The Joint Corp. Reports 2021 Operating Metrics
The Joint Corp. (NASDAQ: JYNT) reported significant growth in 2021, with a 39% increase in system-wide sales and 29% rise in comp sales compared to 2020. The company performed 10.9 million patient visits and treated 807,000 new patients, marking substantial year-over-year improvements. The total number of clinics grew to 706, with 130 new locations opened during the year, up from 73 in 2020. The company aims to accelerate growth further, targeting 1,000 clinics by the end of 2023.
- 39% increase in system-wide sales compared to 2020.
- 29% increase in comp sales compared to 2020.
- 10.9 million patient visits, up from 8.3 million in 2020.
- Opened 130 new clinics, significantly up from 73 in 2020.
- None.
- Grows Annual System-Wide Sales
- Increases Comp Sales of
- Opens 130 New Clinics, Up from 73 in 2020 -
SCOTTSDALE, Ariz., Jan. 10, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, provided operating metrics for the year ended 2021.
2021 Full Year Operating Highlights
- Performed 10.9 million patient visits, up from 8.3 million in 2020 and 7.7 million in 2019.
- Treated 807,000 new patients, up from 584,000 in 2020 and 585,000 in 2019.
- Increased system-wide sales1
39% , up from18% in 2020 and from33% in 2019. - Delivered comp sales2 of
29% , up from9% in 2020 and25% in 2019. - Sold 156 franchise licenses, compared to 121 in 2020 and 126 in 2019.
- Grew total clinics to 706 at December 31, 2021, 610 franchised and 96 company-owned or managed, up from 579 at December 31, 2020. During 2021, the company acquired 12 franchised clinics and closed 3 clinics. It also opened 110 franchised and 20 corporate greenfield clinics, for a total of 130 new clinics in 2021, as compared to 73 new clinics opened in 2020 and 76 in 2019.
“We are proud of our doctors, wellness coordinators, entire community of franchisees, and corporate staff who consistently work to achieve our mission of improving quality of life through routine and affordable chiropractic care,” stated Peter D. Holt, President and Chief Executive Officer of The Joint Corp. “Once again, they rose to the occasion, delivering record breaking operational performance in 2021. In 2022, we plan to accelerate our clinic opening momentum as we march toward our goal of 1,000 clinics opened by the end of 2023.”
About The Joint Corp. (NASDAQ: JYNT)
The Joint Corp. revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation’s largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company makes quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. With over 700 locations nationwide and nearly eleven million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. Ranked number one on Forbes’ 2022 America's Best Small Companies list, number three on Fortune’s 100 Fastest-Growing Companies list and consistently named to Franchise Times “Top 400+ Franchises” and Entrepreneur’s “Franchise 500®” lists, The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit www.thejoint.com. For franchise opportunities, visit www.thejointfranchise.com.
Business Structure
The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Washington, West Virginia and Wyoming, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.
Forward-Looking Statements
This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, the continuing impact of the COVID-19 outbreak on the economy and our operations (including temporary clinic closures, shortened business hours and reduced patient demand), our failure to develop or acquire company-owned or managed clinics as rapidly as we intend, our failure to profitably operate company-owned or managed clinics, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage, short-selling strategies and negative opinions posted on the internet which could drive down the market price of our common stock and result in class action lawsuits, and the other factors described in “Risk Factors” in our Annual Report on Form 10-K as filed with the SEC for the year ended December 31, 2020, as updated or revised for any material changes described in any subsequently-filed Quarterly Reports on Form 10-Q or other SEC filings. Words such as, "anticipates," "believes," "continues," "estimates," "expects," "goal," "objectives," "intends," "may," "opportunity," "plans," "potential," "near-term," "long-term," "projections," "assumptions," "projects," "guidance," "forecasts," "outlook," "target," "trends," "should," "could," "would," "will," and similar expressions are intended to identify such forward-looking statements. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.
Media Contact: Margie Wojciechowski, The Joint Corp., margie.wojciechowski@thejoint.com
Investor Contact: Kirsten Chapman, LHA Investor Relations, 415-433-3777, thejoint@lhai.com
________________________________________________________________________________________________________________________________________
1 System-wide sales include sales at all clinics, whether operated by the Company or by franchisees. While franchised sales are not recorded as revenues by the Company, management believes the information is important in understanding the Company’s financial performance, because these sales are the basis on which the Company calculates and records royalty fees and are indicative of the financial health of the franchisee base.
2 Comp sales include the sales from both company-owned or managed clinics and franchised clinics that in each case have been open at least 13 full months and exclude any clinics that have closed, respectively.
FAQ
What were The Joint Corp.'s (JYNT) system-wide sales growth figures for 2021?
How many new clinics did The Joint Corp. (JYNT) open in 2021?
What is the comp sales increase for The Joint Corp. (JYNT) in 2021?
How many patient visits did The Joint Corp. (JYNT) report in 2021?
